| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0001 |